Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials

Highlights • QIV was as immunogenic as TIV against the shared three strains included in the TIV. • QIV had superior efficacy to the alternate B lineage (non-TIV B lineage). • Safety profile of QIV was tolerable.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 2016-07, Vol.34 (35), p.4092-4102
Hauptverfasser:	Moa, Aye M, Chughtai, Abrar A, Muscatello, David J, Turner, Robin M, MacIntyre, C. Raina
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Age Allergy and Immunology Drug-Related Side Effects and Adverse Reactions Humans Immunogenicity Immunogenicity, Vaccine Infections Influenza Influenza vaccine Influenza Vaccines - adverse effects Influenza Vaccines - immunology Influenza, Human - prevention & control Intramuscular Meta-analysis Older people Population QIV Quadrivalent Randomized Controlled Trials as Topic Seroconversion Studies Vaccines Vaccines, Inactivated - adverse effects Vaccines, Inactivated - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights • QIV was as immunogenic as TIV against the shared three strains included in the TIV. • QIV had superior efficacy to the alternate B lineage (non-TIV B lineage). • Safety profile of QIV was tolerable.
ISSN:	0264-410X 1873-2518
DOI:	10.1016/j.vaccine.2016.06.064